Tech Company Financing Transactions
Pharma Two B Funding Round
Pharma Two B closed a $30 million funding round on 2/28/2017. Backers included Israel Biotech Fund and Generali Financial Holdings.
Transaction Overview
Company Name
Announced On
2/28/2017
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Israel Biotech Fund (Lead Investor) (Jeffrey Kindler)
Proceeds Purpose
Pharma Two B's announcement states that the funds raised will be used to complete the final pivotal phase III clinical trial needed to register P2B001, the company's lead combination product for the treatment of Parkinson's disease.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Pekeris St. Weizmann Science Park
Rehovot, 76702
Israel
Rehovot, 76702
Israel
Phone
Website
Email Address
Overview
Pharma Two B develops clinically differentiated and value-added products, based on approved drugs, with complementary and synergistic effects and optimized delivery profiles, providing high clinical value and shorter regulatory pathways (US 505b2 approach).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nurit Livnah
Chief Financial Officer
Irit Zalayet
VP - Bus. Development
Moran Shapira
VP - Regulatory Affairs
Hadas Friedman
Browse more venture capital transactions:
Prev: 2/28/2017: Dubset Media Holdings venture capital transaction
Next: 3/1/2017: Freenome venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs